These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 37972928

  • 1. Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.
    Hyrcza MD, Martins-Filho SN, Spatz A, Wang HJ, Purgina BM, Desmeules P, Park PC, Bigras G, Jung S, Cutz JC, Xu Z, Berman DM, Sheffield BS, Cheung CC, Leduc C, Hwang DM, Ionescu D, Klonowski P, Chevarie-Davis M, Chami R, Lo B, Stockley TL, Tsao MS, Torlakovic E.
    Mod Pathol; 2024 Jan; 37(1):100384. PubMed ID: 37972928
    [Abstract] [Full Text] [Related]

  • 2. Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions.
    Adam J, Stang NL, Uguen A, Badoual C, Chenard MP, Lantuéjoul S, Maran-Gonzalez A, Robin YM, Rochaix P, Sabourin JC, Soubeyran I, Sturm N, Svrcek M, Vincent-Salomon A, Radosevic-Robin N, Penault-Llorca F.
    Mod Pathol; 2023 Aug; 36(8):100192. PubMed ID: 37084942
    [Abstract] [Full Text] [Related]

  • 3. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, Arcila ME, Dogan S, Klimstra DS, Ladanyi M, Jungbluth AA.
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [Abstract] [Full Text] [Related]

  • 4. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A, Mansukhani MM, Fernandes H, Hsiao SJ.
    Cancer Genet; 2022 Apr; 262-263():47-52. PubMed ID: 35007853
    [Abstract] [Full Text] [Related]

  • 5. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
    Haberecker M, Töpfer A, Melega F, Moch H, Pauli C.
    Histopathology; 2023 Jun; 82(7):1003-1012. PubMed ID: 36759438
    [Abstract] [Full Text] [Related]

  • 6. Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
    Brčić I, Godschachner TM, Bergovec M, Igrec J, Till H, Lackner H, Scheipl S, Kashofer K, Brodowicz T, Leithner A, Szkandera J, Liegl-Atzwanger B.
    Mod Pathol; 2021 Feb; 34(2):396-407. PubMed ID: 32860002
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
    Su YJ, Lee YH, Jin YT, Hsieh MS.
    Appl Immunohistochem Mol Morphol; 2022 Apr 01; 30(4):264-272. PubMed ID: 35384876
    [Abstract] [Full Text] [Related]

  • 9. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma.
    Macerola E, Proietti A, Poma AM, Vignali P, Sparavelli R, Ginori A, Basolo A, Elisei R, Santini F, Basolo F.
    Int J Mol Sci; 2022 Jul 05; 23(13):. PubMed ID: 35806472
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.
    De Winne K, Sorber L, Lambin S, Siozopoulou V, Beniuga G, Dedeurwaerdere F, D'Haene N, Habran L, Libbrecht L, Van Huysse J, Weynand B, Wouters K, Pauwels P, Zwaenepoel K.
    Virchows Arch; 2021 Feb 05; 478(2):283-291. PubMed ID: 32915263
    [Abstract] [Full Text] [Related]

  • 11. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
    Csanyi-Bastien M, Lanic MD, Beaussire L, Ferric S, François A, Meseure D, Jardin F, Wassef M, Ruminy P, Laé M.
    Am J Surg Pathol; 2021 Nov 01; 45(11):1487-1498. PubMed ID: 33899788
    [Abstract] [Full Text] [Related]

  • 12. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.
    Endocr Pathol; 2020 Dec 01; 31(4):348-358. PubMed ID: 32880785
    [Abstract] [Full Text] [Related]

  • 13. The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study.
    Van Bockstal MR, Beniuga G, Craciun L, Creytens D, Dedeurwaerdere F, Delvenne P, Demetter P, De Wiest B, Dewinne K, Habran L, Pauwels P, Theate I, Vander Borght S, Van Der Steen K, Weynand B.
    Pathobiology; 2022 Dec 01; 89(6):393-406. PubMed ID: 35350025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER, Lockwood CM, Stohr BA, Vargas SO, Sheridan R, Black JO, Rajaram V, Laetsch TW, Davis JL.
    Am J Surg Pathol; 2018 Jul 01; 42(7):927-935. PubMed ID: 29683818
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases.
    Chou A, Fraser T, Ahadi M, Fuchs T, Sioson L, Clarkson A, Sheen A, Singh N, Corless CL, Gill AJ.
    Mod Pathol; 2020 May 01; 33(5):924-932. PubMed ID: 31792356
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Pan-TRK Antibody is a Sensitive and Specific Tool for the Detection of NTRK Fusion Genes.
    Bautista-Wong C, Mojica-González Z, Hop-Garcia K, Bornstein Quevedo L.
    Appl Immunohistochem Mol Morphol; 2023 Apr 01; 31(4):213-216. PubMed ID: 37017998
    [Abstract] [Full Text] [Related]

  • 20. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
    Zhang Z, Pang J, Chen L, Chen J, Li J, Liu H, Wang J, Wu H, Liang Z.
    Hum Pathol; 2022 Nov 01; 129():21-31. PubMed ID: 35977594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.